Supplementary Table 2 from Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Authors :: Jan C. Buckner
Timothy J. Kaufmann
Kurt A. Jaeckle
Patrick J. Flynn
Donald W. Northfelt
Teresa K. Kimlinger
Shaji K. Kumar
Caterina Giannini
Joon H. Uhm
Jackie M. Lafky
S. Keith Anderson
Evanthia Galanis
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table 2 - PDF file 54K, SNPs Analyzed and Genotype Frequencies

Full Text Access

Tools